Subsequent immunohistochemical analysis of Ki67 (proliferation marker) and N-cadherin (EMT marker) revealed that DGE potentiated DOX’s anti-DLBCL effects, as shown by decreased Ki67- and N-cadherin-positive cells (Fig. 3E, F). This evidence concerns the gene CDH2 and diffuse large B-cell lymphoma.